Ionis Pharmaceuticals Inc. Common Stock vs The Magnum Ice Cream Company N.V. Ordinary Shares — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B), while The Magnum Ice Cream Company N.V. Ordinary Shares trades at $17.92 (market cap $10.72B). The key difference: The Magnum Ice Cream Company N.V. Ordinary Shares is the larger of the two by market cap, and The Magnum Ice Cream Company N.V. Ordinary Shares is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and The Magnum Ice Cream Company N.V. Ordinary Shares for 0 Days on average.
| IONS | MICC | |
|---|---|---|
Market Cap | $7.04B | $10.72B |
Volume | 2,977,440 | 1,309,650 |
Sector | Health | Consumer Staples |
52-Week High | $86.50 | $20.42 |
52-Week Low | $42.38 | $13.06 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $6.60B | $14.14B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →The Magnum Ice Cream Company N.V. manufactures and sells ice cream and frozen desserts through brands including Magnum, Ben & Jerry's, Wall's, and Cornetto, distributing across roughly 80 countries.
Read more on MICC →